By Ronny Hyman:
In June, the FDA indicated the neostigmine methylsulfate shortage had been resolved.
Recent public evidence that unapproved formulations of neostigmine will no longer be marketed after September 30, 2014 sets the stage for market...
MannKind (NASDAQ: MNKD) shares moved up 11.30% to $11.13. The volume of MannKind shares traded was 784% higher than normal. MannKind jumped following the conditional FDA approval for Afrezzaa.
Dicerna Pharmaceuticals (NASDAQ: DRNA) shares rose...
Carmax, Inc. (NYSE: KMX) 17.9% HIGHER; reported Q1 EPS of $0.76, $0.09 better than the analyst estimate of $0.67. Revenue for the quarter came in at $3.75 billion versus the consensus estimate of $3.6 billion. Used comps rose 3.4 percent.
Flamel Technologies S.A. (FLML)
Q1 2014 Earnings Call
May 12, 2014 10:00 AM ET
Michael Anderson – CEO
Sian Crouzet – Principal Financial Officer
Steven Lisi – Senior Vice President, Business and Corporate...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.